Monday, July 13, 2026

Federal prosecutors indicted 13 individuals across five states for a scheme involving fraudulent genetic cancer testing. The defendants, including marketing agents and telemedicine providers, are accused of paying kickbacks, submitting claims for medically unnecessary tests, and laundering proceeds from Medicare and Medicaid. This large-scale enforcement action signals intensified DOJ and OIG scrutiny of lab billing, particularly for high-cost genomic panels. Practices ordering similar tests should ensure documentation substantiates medical necessity for every test, as audit contractors will likely increase reviews in this area.

Budget cuts to Oklahoma's Medicaid program will further strain rural health care capacity. The reductions come as rural hospitals in the state and across the Midwest face closure risks, limiting where Medicaid patients can receive care. Billing teams should monitor patient mix and payer volume shifts in affected regions, as lower Medicaid reimbursement and reduced access points can increase uncompensated care burdens for independent practices serving these communities.

Arkansas implements new Medicaid work requirements for able-bodied adults, a policy shift that risks coverage loss for thousands. The change arrives during a period of instability for the state's health system, with rural hospital closures and provider shortages. Practices in Arkansas should prepare for potential increases in uninsured patient visits and more complex eligibility verification workflows. Track the state's monthly disenrollment reports to anticipate local impacts on patient volume and bad debt.

Iowa-based UnityPoint Health confirmed it is outsourcing some revenue cycle management and IT positions. While the health system cited a need to adapt and reduce costs, the move reflects the broader financial strain on provider revenue operations from rising denial rates, prior authorization burdens, and shrinking margins. For independent practices, this is a market signal of intensifying operational pressure, where even large systems seek external solutions for core billing functions.

A new analysis argues that framing prior authorization as a mere efficiency problem misreads the conflict. The core issue remains a fundamental disagreement over medical necessity, where payers use PA to manage costs and providers see it as care interference. While vendors pitch AI for faster determinations, this does not resolve the underlying tension over what services should be covered. For billing teams, this means the operational burden and denial risk from PA are structural, not just technical.